Establishment of cell line derived from human malignant melanoma. 1978

J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová

A new human cell line of malignant melanoma (MJM) was established with the use of the in vitro fragment technique. It has been maintained over 34 months of continuous cultivation. Three types of cells can be recognized by light microscope. The epitheloid elements predominate, less frequent are fibroblastoid and giant multinuclear cells. The pigment production is not macroscopically visible. Over 60 per cent of analyzed metabphases showed hyperdiploid number of chromosomes, the rest was mostly tetra and hexaploid. No marker chromosomes were detected. The growth studies indicate the MJM cells have 63-hr doubling time. Cytochemistry revealed positive pigment or propigment granules in 36 per cent of cells. Ultrastructural studies did not detect melanin granules but some particles resembling atypical premelanosomes and melanosomes were recognized in some sections.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D003594 Cytoplasmic Granules Condensed areas of cellular material that may be bounded by a membrane. Cytoplasmic Granule,Granule, Cytoplasmic,Granules, Cytoplasmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
June 1998, Human cell,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
December 1980, Nihon juigaku zasshi. The Japanese journal of veterinary science,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
December 1971, Gan,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
January 1974, In vitro,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
March 2005, Human cell,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
August 2001, Pathology international,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
January 1988, Cellular and molecular biology,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
October 1968, Journal of the National Cancer Institute,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
February 1983, British journal of experimental pathology,
J Kovarík, and J Svejda, and J Bucek, and A Rejthar, and B Král, and E Ninger, and D Zemanová, and L Lauerová
February 1994, Pathology, research and practice,
Copied contents to your clipboard!